Team @cellogenindia wishes you a very Happy Dussehra! #ThalassemicsIndia #Dussehra #Dussehra2026 #StrengthAndHope #ThalassemiaAwareness #TogetherWeCan

Dr. Sangam Goswami explains how gene editing works. When an error occurs in our genetic code, gene editing can act like molecular scissors—targeting the error and replacing it with the correct sequence. @cellogenindia @DrGKharya #GeneEditing #GeneTherapy #DrSangamGoswami #CellogenTherapeutics #GeneticMedicine

For Dr. Sangam Goswami at Cellogen Therapeutics, sickle cell research is personal. His journey fuels his mission to make gene therapies more affordable and accessible. @cellogenindia @DrGKharya #CellogenTherapeutics #SickleCellDisease #GeneTherapy #MedicalResearch

Two milestones. One shared mission: advancing patient care. From DCGI approval for our first-in-human clinical trial of B-cell–specific gene therapy to the development of CiRA AI, Team Cellogen is taking meaningful steps towards making innovative healthcare solutions a reality. Every milestone brings us closer to new possibilities for patients. @cellogenindia @CDSCO_INDIA_INF #TeamCellogen #GeneTherapy #CiRAAI #CellAndGeneTherapy #InnovationInHealthcare #PatientCare

Not all science briefings are boring. Science, smiles, and a little fun in between! #TeamCellogen #CellogenTherapeutics #LifeAtCellogen #ScienceAndInnovation #TeamFun #WorkCulture

Team Cellogen wishes you and your family a very Happy Ganesh Chaturthi!! #HappyGaneshChaturthi #GanpatiBappaMorya #GaneshChaturthi #teamcellogen

Once considered a life-threatening diagnosis with limited treatment options, Acute Lymphoblastic Leukemia (ALL) is now highly treatable, especially when diagnosed and treated on time. @DrGKharya speaks about the remarkable progress in ALL treatment—and why timely diagnosis and the right treatment can make all the difference. Stay tuned to watch the full podcast. @cellogenindia #DrGauravKharya #ALL #AcuteLymphoblasticLeukemia #ChildhoodCancer #BloodCancer #CancerCare #cellogenpodcast

@cellogenindia proudly introducing CiRA AI — an intelligent AI platform designed to bring clinical trials and regulatory affairs.Clinical trials often operate across disconnected systems, with patient data, clinical review, regulatory processes and study oversight managed separately. CiRA AI brings these critical layers together in one intelligent environment.Built around three core users — patients, clinical data coordinators and clinicians — the platform brings together clinical data management, patient-reported outcomes, review workflows, regulatory oversight and AI-assisted intelligence. What makes this milestone especially meaningful is that CiRA AI has been built iteratively by our own team — Nisha, Rohit, Utkarsh, Adnan, Priya from defining clinical workflows and logic to designing, testing and refining the platform. #CellogenTherapeutics #CiRAAI #ArtificialIntelligence #AIinHealthcare #HealthcareAI #ClinicalTrials #ClinicalResearch #RegulatoryAffairs #DigitalHealth #HealthTech #MedTech #teamcellogen

@cellogenindia wishes you and your loved ones a Happy Raksha Bandhan! #HappyRakshaBandhan #RakshaBandhan #BondsThatMatter #Togetherness #CellogenTherapeutics #HappyRakhi

We’re proud to share a new milestone at @cellogenindia Our team has filed a provisional patent for: “System and Method for Adaptive Context-Aware Multi-Agent Artificial Intelligence-Based Oncology Decision Support.” A collaborative effort by Dr. Nisha Chaudhary, Rohit, Utkarsh and Syed Adnan this work advances our vision of building intelligent, context-aware AI systems for oncology and CAR-T decision Bringing AI closer to precision cancer care. #CellogenTherapeutics #AIinHealthcare #OncologyAI #ArtificialIntelligence #CancerCare #PrecisionOncology #CAR_T #CARTTherapy #HealthcareInnovation #MedicalAI

See how the CAR-T AI Agent can benefit patients, researchers, and clinicians, as Utkarsh Singh explains its role in making CAR-T therapy information more accessible and reliable. #CARTAI #CARTCellTherapy #CARThealthcare #AIinHealthcare #CancerResearch #CellTherapy #CancerCare #HealthcareAI #MedicalAI #ClinicalResearch #Biotechnology #CellTherapyResearch

Team Cellogen wishes you a very Happy Independence Day! #HappyIndependenceDay #IndependenceDay #ProudIndian #HealthcareInnovation #MadeInIndia

@cellogenindia is proud to announce the appointment of Rohit Shukla as Manager, AI Products & Innovation. Rohit pursued his Project Fellowship at @IITKanpur, in the Department of BSBE, and holds a B.Tech in Computer Science Engineering with a specialization in Artificial Intelligence. He brings close to 3 years of experience leading AI-driven projects in the healthcare domain, with a strong track record of turning complex technical work into scalable, real-world outcomes. At Cellogen Therapeutics, Rohit will lead AI-driven initiatives, working closely with cross-functional teams to drive innovation and deliver impactful, technology-first solutions. With his strong foundation in AI and hands-on project leadership experience, Rohit is committed to building high-performing systems that create real value. We are delighted to welcome Rohit to the team and look forward to his leadership in driving our AI initiatives forward. #CellogenTherapeutics #TeamCellogen #NewAppointment #AIInnovation #ArtificialIntelligence #AIinHealthcare #HealthcareTechnology #HealthTech #AIProducts #Innovation #Teamcellogen

Introducing Cellogen's Next Generation qPCR Quantitation Kits AmpRQuant™ – Ampicillin Resistance Gene Quantification Kit Rapid and accurate quantification of the Ampicillin Resistance (AmpR) gene. KanRQuant™ – Kanamycin Resistance Gene Quantification Kit Sensitive and reliable quantification of the Kanamycin Resistance (KanR) gene. PlasmidTrace™ – Residual Plasmid DNA Quantification Kit Sensitive detection and quantification of residual plasmid DNA to support process validation and regulatory compliance. @cellogenindia #CellogenTherapeutics #qPCR #QuantitationKits #MolecularBiology #Biotechnology #LifeSciences #GeneQuantification #AmpRQuant #KanRQuant #PlasmidTrace #ResidualDNA #teamcellogen

Introducing iTaq, a TAQ DNA polymerase that powers your PCR with confidence. iTaq is a highly thermostable recombinant DNA Polymerase, derived from Thermus aquaticus and produced through recombinant expression in E. coli. Engineered for enhanced anti-interference performance, it delivers robust, reliable, and consistent PCR amplification for demanding molecular biology applications. @cellogenindia #CellogenTherapeutics #iTaq #TAQPolymerase #DNAPolymerase #PCR #PCRAmplification #MolecularBiology #LifeSciences #Biotechnology #Genomics #MolecularDiagnostics #ResearchTools